AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021
LATHAM, N.Y.–(BUSINESS WIRE)–Sep. 15, 2021– AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular…
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
Vascular Interventions & Therapies
Introducing the Next Generation of Peripheral Atherectomy Technology
“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment…
Making a Material Difference.
The BioFlo PICC is the first PICC of its kind with Endexo Technology, providing a catheter more resistant to the…
Solero Microwave Tissue Ablation System
The Solero* Microwave Tissue Ablation (MTA) System and Accessories are indicated for the ablation of soft tissue during open procedures….
Our Culture is Our Success
Become a proud member of our team
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.